Beta Bionics, Inc. BBNX recently entered into a strategic agreement with Abbott Laboratories ABT to integrate its iLet Bionic Pancreas automated insulin delivery (AID) system with Abbott's upcoming ...

The market expects Beta Bionics, Inc. (BBNX) to deliver a year-over-year increase in earnings on higher revenues when it ...

We recently published a list of 10 Stocks With At Least $10 Million In Insider Spending Recently. In this article, we are going to take a look at where Beta Bionics, Inc. (NASDAQ:BBNX) stands against ...

As per the analyst, the insulin pumps are a double-digit growth category, with the company taking share from the low base. The firm believes that Beta Bionics, Inc. (NASDAQ:BBNX)’s revenue in the US ...

$BBNX ($BBNX) is expected to release its quarterly earnings data on Tuesday, March 25th after market close, per Finnhub. Analysts are expecting revenue of $20,590,566 ...

Beta Bionics, Inc. (BBNX) came out with a quarterly loss of $0.3 per share versus the Zacks Consensus Estimate of a loss of $0.42. This compares to a loss of $1.82 per share a year ago. These figures ...

Detailed price information for Beta Bionics Inc (BBNX-Q) from The Globe and Mail including charting and trades.

The latest price target for Beta Bionics (NASDAQ:BBNX) was reported by Goldman Sachs on October 29, 2025. The analyst firm set a price target for $33.00 expecting BBNX to rise to within 12 months (a ...

Wilson Encourages Investors Who Suffered Significant Losses In Aquestive Therapeutics To Contact Him Directly To Discuss Their Options ...

Baird has initiated its coverage of newly IPO’d medical device maker Beta Bionics (NASDAQ:BBNX) with a Neutral recommendation and a $20 per share target, citing concerns over the stock’s valuation.